Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy
Figure 3
After doxorubicin treatment (5 mg/kg), bioluminescence imaging was performed to observe caspase activation in 22B-pcFluc-DEVD (adopted from Niu et al. [38]).
